Dysphonia induced by vascular endothelium growth factor/vascular endothelium growth factor receptor inhibitors

Author： Hartl Dana   Ferté Charles   Loriot Yohann   Gomez Roca Carlos   Bahleda Rastislav   Moldovan Cristian   Mir Olivier   Soria Jean-Charles  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.28, Iss.6, 2010-12, pp. : 884-886

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vascular endothelial growth factor tyrosine kinase inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 6, 2004-06 ,pp. : 921-924

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors targeting vascular endothelial growth factor receptor kinases and cyclin-dependent kinases

By  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 3, 2005-03 ,pp. : 337-341

Informa Healthcare

Access to resources Recommend Favorite

Development of Vascular Endothelial Growth Factor Receptor (VEGFR) Kinase Inhibitors as Anti-Angiogenic Agents in Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 11, Iss. 6, 2004-03 ,pp. : 731-745

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular endothelial growth factor inhibitors and cognitive impairment: evidence and controversies

By Ng Terence   Cheung Yin Ting   Ng Quan Sing   Ho Han Kiat   Chan Alexandre  

Expert Opinion on Drug Safety, Vol. 13, Iss. 1, 2014-01 ,pp. : 83-92

Informa Healthcare

Access to resources Recommend Favorite

Involvement of insulin-like growth factor 1 receptor transactivation in endothelin-1-induced signaling in vascular smooth muscle cells

By Bouallegue Ali   Vardatsikos George   Srivastava Ashok K.  

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 5, 2010-05 ,pp. : 501-509

NRC Research Press

Access to resources Recommend Favorite